Insider · CIK 0001818520
Douglas Love
Files at ANNX (Annexon, Inc.). First filing Feb 18, 2025, latest Sep 25, 2026.
In brief
Douglas Love files SEC Form 4 as CEO, president and director at ANNX (Annexon, Inc.). Since Feb 18, 2025, Douglas Love has reported 1 open-market buy worth $100k and 1 open-market sell worth $15k, the latest filed on Sep 25, 2026.
A track record needs three past buys with six months of prices behind them; Douglas Love has 0, so none is measured yet.
The newest scored trade: bought $100k of ANNX on Sep 24, 2026, filed Sep 25, 2026, scored 46 (moderate). In the last 12 months: 1 buy worth $100k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANNX: Annexon, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ANNXbuy Annexon, Inc. | $100k 26,065 shares | +7% | +42% from low-45% from high | |
| 40Moderate | Annexon, Inc. | $15k 5,021 shares | -1% | +0% from low-61% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 13, 2025 | ANNX Annexon, Inc. | 5,021 0.00% of outstanding | $15k | Feb 13, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ANNX Annexon, Inc. | POpen-market purchase Common Stock | +26,065 | $3.83 | $100k | 390,476 | 18 d ago |
| Feb 19, 2026 | ANNX Annexon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,250,000 | $0.00 | $0 | 1,250,000 | Feb 23, 2026 |
| Feb 27, 2025 | ANNX Annexon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,300,000 | $0.00 | $0 | 1,300,000 | Mar 3, 2025 |
| Feb 13, 2025 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -5,021 | $2.95 | $15k | 351,554 | Feb 18, 2025 |
| Jan 6, 2025 | ANNX Annexon, Inc. | MOption exercise Common Stock | +37,994 | $1.41 | $54k | 356,575 | Jan 8, 2025 |
| Jan 6, 2025 | ANNX Annexon, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -37,994 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Oct 30, 2024 | ANNX Annexon, Inc. | MOption exercise Common Stock | +78,399 | $1.85 | $145k | 274,520 | Nov 1, 2024 |
| Oct 30, 2024 | ANNX Annexon, Inc. | MOption exercise Common Stock | +36,050 | $1.85 | $67k | 310,570 | Nov 1, 2024 |
| Oct 30, 2024 | ANNX Annexon, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -78,399 | $0.00 | $0 | 0 | Nov 1, 2024 |
| Oct 30, 2024 | ANNX Annexon, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -36,050 | $0.00 | $0 | 0 | Nov 1, 2024 |
Questions about Douglas Love
Answered from the filings on this page, as of the latest one.
Is Douglas Love buying or selling?
In the last 12 months Douglas Love reported 1 open-market buy worth $100k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of ANNX on Sep 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Douglas Love's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas Love has 0.
Where does Douglas Love file Form 4?
Douglas Love has filed Form 4 at ANNX (Annexon, Inc.) as PRESIDENT AND CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.